Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Past hour
    • Any time
    • Past 24 hours
    • Past 7 days
    • Past 30 days
7m

Beacon Therapeutics Treats First Patient in LANDSCAPE Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP)

Laru-zova is investigational and has not been approved by FDA for use.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

NYE bombing plot arrests
Hires former CDC leaders
R&B legend dies at 72
Grand Canyon to reopen hotels
'NCIS: LA' actress dies at 45
US offers security guarantee
SF cable car incident
Today in history: 1995
Trial begins for WI judge
MRI confirms torn ACL
Flash flood warning in Seattle
Disbarred in Connecticut
Sentenced to 30 years
Injured leaving Venezuela?
FDA warns retailers
Steve Taneyhill dies
Spotify suffers outages
Portugal to host F1
‘General Hospital’ star dies
BU shooting victims ID'd
Trump sues BBC
Bedard placed on IR
Brian Walshe found guilty
Frozen sliders recalled
Simmons' home burglarized
Jets fire DC Steve Wilks
Soldiers killed in Syria ID’d
Luminar files for bankruptcy
Returns as PGA Tour sponsor
Trump flags illicit fentanyl
FTC, states file amended suit
Feedback
  • Privacy
  • Terms